Park Ha Biological Technology Co., Ltd. - Class A Ordinary Shares (BYAH)

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Park Ha Biological Technology Co. Ltd. (NASDAQ: BYAH) resulting from allegations that Park Ha Biological may have issued materially misleading business information to the investing public.

As digital securities, blockchain-based preferred stock , and tokenized equity frameworks move from concept to real-world execution, early adopters are positioned to benefit most . Full Alliance Group’s (OTC: FAGI ) first-mover position in compliant, blockchain-verified preferred equity , combined with real operating businesses and strategic digital infrastructure exposure , creates a rare asymmetric opportunity within the OTC market.

Wuxi, China, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (the “Company”) today announced the closing of a best-efforts follow-on public offering of 21,875,000 units (each a “Unit”) at an offering price of US$0.112 per Unit.

Wuxi, China, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (the “Company”) today announced the pricing of a best-efforts follow-on public offering of 21,875,000 units (each a “Unit”) at an offering price of US$0.112  per Unit.